| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 09/24/2008 | CN101270092A Method for synthesizing neotame |
| 09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/18/2008 | WO2008111631A1 METHOD FOR PRODUCING α-METHYLBENZYLAMINE SALT |
| 09/18/2008 | WO2008111295A1 Agent for prevention and/or treatment of systemic lupus erythematosus |
| 09/18/2008 | WO2008110611A1 Organic compounds and their uses |
| 09/18/2008 | WO2008074803A3 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists |
| 09/18/2008 | US20080227882 Multifunctional Monomers Containing Bound Poragens and Polyarylene Compositions Therefrom |
| 09/18/2008 | US20080227790 treating an airway disorder; 4-(3-{3,4-dimethoxyphenyl}-5,5-dimethyl-6-oxo-5,6-dihydro-4H-pyridazin-1-yl)-benzoic acid |
| 09/18/2008 | CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | CN100418952C Biphenyl derivatives and their use as fungicides |
| 09/16/2008 | US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 09/16/2008 | US7425556 Compounds and uses thereof |
| 09/12/2008 | WO2008108842A1 Lisofylline analogs and methods for use |
| 09/12/2008 | CA2679301A1 Lisofylline analogs and methods for use in protecting pancreatic .beta.-cells, treating type 1 diabetes, and treating inflammatory and autoimmune diseases |
| 09/11/2008 | US20080221110 Tricyclic condensed ring nitrogen compound selectively acts on cannabinoid receptors; Gram-negative and Gram-positive bacterial infections; 1-({4-[(6,7-Dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one |
| 09/11/2008 | US20080219922 Alzheimer's Disease Imaging Agents |
| 09/10/2008 | EP1967516A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases |
| 09/10/2008 | EP1966158A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 09/10/2008 | EP1966144A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/09/2008 | US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/04/2008 | US20080214552 Substituted Pyridazinecarboxamides and Derivatives Thereof |
| 09/04/2008 | US20080214549 N-Substituted Glycine Derivatives: Hydroxylase Inhibitors |
| 09/04/2008 | US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 09/03/2008 | EP1963273A2 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitors |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 08/28/2008 | WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 08/28/2008 | WO2008101615A1 Method for producing 4,5-dihalogen-2-aryl-2h-pyridazin-3-ones |
| 08/28/2008 | WO2008101614A1 Method for producing 4-(3-hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2h)-ones |
| 08/28/2008 | WO2008101613A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy-5-[4-methylsulfonyl)phenyl]-3(2h)-pyridazinone (fhmp) |
| 08/28/2008 | WO2008059513A3 Compounds suitable as modulators of hdl |
| 08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
| 08/28/2008 | US20080207622 Soluble epoxide hydrolase inhibitors |
| 08/28/2008 | US20080207621 Use treating hypertensive, cardiovascular, inflammatory, pulmonary, and diabetes-related diseases; compounds are aminosulfonylphenyl urea or thiourea e.g. 4-(3-Adamantan-1-yl-ureido)-N-(2-morpholin-4-yl-ethyl)-benzenesulfonamide |
| 08/28/2008 | US20080207587 Pyridazine Derivatives for Inhibiting Human Stearoyl-Coa-Desaturase |
| 08/28/2008 | DE102007008843A1 Verfahren zur Herstellung von 4,5-Dihalogen-2-aryl-2H-pyridazin-3-onen Process for the preparation of 4,5-dihalo-2-aryl-2H-pyridazin-3-ones |
| 08/28/2008 | DE102007008840A1 Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP) Novel polymorph of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -5- [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP) |
| 08/28/2008 | DE102007008839A1 Verfahren zur Herstellung von 4-(3-Hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2H)-onen Process for the preparation of 4- (3-hydroxy-3-methyl-butoxy) -5- [4- (methylsulfonyl) phenyl] -2-arylpyridazin-3 (2H) -ones |
| 08/28/2008 | CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 08/27/2008 | EP1960370A1 Pyridiazinone derivatives for tumour treatment |
| 08/27/2008 | CN101253157A Method for producing 2, 3-dihydropyridazine compound |
| 08/26/2008 | CA2387920C A new use of levosimendan |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/21/2008 | WO2008098958A1 C-terminal attachment of two chemical groups to peptides |
| 08/21/2008 | WO2008098892A1 Fast dissociating dopamine 2 receptor antagonists |
| 08/21/2008 | WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 08/21/2008 | WO2007037898A8 Theramutein modulators |
| 08/21/2008 | US20080200473 GABA a receptor; hypnotic agents with a lower risk of side effects; sleep, sedative, muscle relaxant; 4-Dimethylamino-N-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-ylmethyl)-benzamide |
| 08/21/2008 | US20080200472 urinary incontinence, ulcer, inflammatory bowel disease, addiction, Parkinson's, anxiety, epilepsy, seizures, pruritus, psychosis, cognitive disorder, Huntington's chorea, ALS, retinopathy, migraine, vomiting, dyskinesia, depression; Pyridazinylpiperazine compounds; VR1 Vanilloid Receptor 1 antagonists |
| 08/21/2008 | US20080200469 Phthalazinone derivatives |
| 08/21/2008 | US20080199427 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C |
| 08/21/2008 | CA2674752A1 3,4-dihydropyrrolo[1,2-a]pyrazin-1-yl amines useful as fast dissociating dopamine 2 receptor antagonists |
| 08/20/2008 | CN101248156A Novel materials for organic electroluminescent devices |
| 08/20/2008 | CN100412064C Malononitrile compounds and its use |
| 08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
| 08/14/2008 | US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound |
| 08/14/2008 | US20080194583 Tubulin Inhibitors |
| 08/14/2008 | US20080194569 Phthalazinones |
| 08/14/2008 | US20080194566 3-chloro-5-(4-chlorophenyl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine; 4,5-diphenyl-6-alkyl-,2H-pyridazin-3-one, 4-(2,6-difluoro-4-aminophenyl)-5-phenyl-6-alkylpyridazine, and 3,4-diphenyl-5-alkyl-5-hydroxy furanone intermediates; a fungicide controlling plant diseases for agriculture or gardening |
| 08/07/2008 | WO2008093495A1 Agent for treatment of multiple sclerosis |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188477 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 08/07/2008 | US20080188371 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat) |
| 08/07/2008 | CA2669563A1 Agent for treatment of multiple sclerosis |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | CA2286796C Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 07/31/2008 | WO2008090884A1 Novel trifluoromethylphenyltetrahydrocinnoline derivative and pharmaceutical use thereof |
| 07/31/2008 | WO2008090353A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | WO2008089934A1 Pyridazine derivatives, processes for their preparation and their use as fungicides |
| 07/31/2008 | WO2008013838A3 Pyridizinone derivatives |
| 07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
| 07/31/2008 | US20080182846 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 07/31/2008 | CA2675621A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | CA2674931A1 Pyridazine derivatives, processes for their preparation and their use as fungicides |
| 07/30/2008 | EP1948617A2 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/24/2008 | WO2008089052A2 N-substituted glycine derivatives: hydroxylase inhibitors |
| 07/24/2008 | US20080176843 Modulators of muscarinic receptors |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228135A Pyridazinone derivatives as thyroid hormone receptor agonists |
| 07/23/2008 | CN100404516C Process for preparing hexahydro pyridazine tricarboxylate |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/17/2008 | US20080171873 Converting a chiral epoxyester or epoxycarboxamide to a chiral primary epoxyamine with an alkali hypohalite; reducing to form the amine;2-benzyl-4-methyl-4-phenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol; 4-methyl-2,4-diphenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/16/2008 | EP1944289A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/16/2008 | EP1943231A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 07/16/2008 | CN101219996A 4,4í»-di(4-phthalazone base) diphenyl sulfone and method for producing the same |
| 07/15/2008 | US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
| 07/15/2008 | CA2298522C 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 07/10/2008 | US20080167461 Process for Preparing 3,6-Dichloropyridazine-1-Oxide |
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |